Astrana Health Inc (ASTH)
Return on equity (ROE)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 60,717 | 45,171 | 68,923 | 37,688 | 14,116 |
| Total stockholders’ equity | US$ in thousands | 614,218 | 542,561 | 448,167 | 330,824 | 191,549 |
| ROE | 9.89% | 8.33% | 15.38% | 11.39% | 7.37% |
December 31, 2023 calculation
ROE = Net income ÷ Total stockholders’ equity
= $60,717K ÷ $614,218K
= 9.89%
The return on equity (ROE) for Astrana Health Inc has shown a fluctuating trend over the past five years. In 2023, the ROE stood at 9.89%, representing a slight improvement from the previous year's 8.33%. In 2021, the ROE peaked at 15.38%, indicating a strong performance in generating profits from shareholders' equity. In comparison, the ROE was lower in 2020 at 11.39% and in 2019 at 7.37%. Overall, Astrana Health Inc's ROE has demonstrated variability over the years, with fluctuations in profitability relative to shareholder equity.